Main menu

New modality

Members

Representative Sponsor Motoya Nishikawa
Caretaker Akiko Ishii
Caretaker Masataka Oitate
Caretaker Kazuhisa OZEKI
Caretaker Yoichi Naritomi
Caretaker Shunsuke Yamamoto
Caretaker Takashi Kuwabara
Sponsor Hideman Akita

Outline

 The goal of this DIS is to collect and disseminate information on pharmacokinetic research related to new drug modality. The depletion of drug targets in the development of conventional modality drugs (small molecule drugs and protein drugs) is becoming an issue, and the development of new drugs in new modalities such as antibody-drug conjugates, nucleic acid drugs and cellular drugs is now being actively pursued. We hope that this DIS will function as a hub for the advancement of pharmacokinetic research in these areas.